CCR2 and Alzheimer disease: CCR2, the receptor of CCL2, deficiency resulted in reduction of microglial accumulation and higher brain Aβ levels in mouse model of AD, which might be mediated via suppression of anti-inflammatory molecule, transforming growth factor β (TGF-β) [3].